Collaborative Arrangements (Tables)

9 Months Ended

Sep. 30, 2016

Collaborative Arrangements

Schedule of net revenue recognized under GSK Agreements

	Three months ended September 30,						Nine months ended September 30,
(In thousands)	2016			2015			2016			2015
Royalties from a related party - RELVAR/BREO	$	31,917		$	14,674		$	87,686		$	36,004
Royalties from a related party - ANORO	4,627			2,122			11,976			4,812
Total royalties from a related party	36,544			16,796			99,662			40,816
Less: amortization of capitalized fees paid to a related party	(3,456		)	(3,455		)	(10,368		)	(10,367		)
Royalty revenue	33,088			13,341			89,294			30,449
Strategic alliance - MABA program license	221			221			663			664
Total net revenue from GSK	$	33,309		$	13,562		$	89,957		$	31,113